228 related articles for article (PubMed ID: 22914891)
21. Amelioration of cyclosporine induced nephrotoxicity by dipeptidyl peptidase inhibitor vildagliptin.
Ateyya H
Int Immunopharmacol; 2015 Sep; 28(1):571-7. PubMed ID: 26225924
[TBL] [Abstract][Full Text] [Related]
22. Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells.
Shino Y; Itoh Y; Kubota T; Yano T; Sendo T; Oishi R
Free Radic Biol Med; 2003 Oct; 35(8):966-77. PubMed ID: 14556861
[TBL] [Abstract][Full Text] [Related]
23. Potential role of poly(ADP-ribose) polymerase activation in the pathogenesis of experimental left varicocele.
Tekcan M; Koksal IT; Tasatargil A; Kutlu O; Gungor E; Celik-Ozenci C
J Androl; 2012; 33(1):122-32. PubMed ID: 21436309
[TBL] [Abstract][Full Text] [Related]
24. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
25. PARP inhibition restores erectile function by suppressing corporal smooth muscle apoptosis in diabetic rats.
Li WJ; Zhou J; Li B; Wang H; Peng YB; Wang Z
J Sex Med; 2011 Apr; 8(4):1072-82. PubMed ID: 21235725
[TBL] [Abstract][Full Text] [Related]
26. A preclinical study on the protective effect of melatonin against methotrexate-induced small intestinal damage: effect mediated by attenuation of nitrosative stress, protein tyrosine nitration, and PARP activation.
Kolli VK; Kanakasabapathy I; Faith M; Ramamoorthy H; Isaac B; Natarajan K; Abraham P
Cancer Chemother Pharmacol; 2013 May; 71(5):1209-18. PubMed ID: 23420439
[TBL] [Abstract][Full Text] [Related]
27. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent renoprotective effect of vanillic acid on methotrexate-induced nephrotoxicity via its anti-apoptosis, antioxidant, and anti-inflammatory properties.
Amini N; Shoshtari MH; Nejaddehbashi F; Dianat M; Badavi M
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4195-4204. PubMed ID: 38041776
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of PARP activation by enalapril is crucial for its renoprotective effect in cisplatin-induced nephrotoxicity in rats.
Rani N; Bharti S; Tomar A; Dinda AK; Arya DS; Bhatia J
Free Radic Res; 2016; 50(11):1226-1236. PubMed ID: 27571604
[TBL] [Abstract][Full Text] [Related]
30. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
[TBL] [Abstract][Full Text] [Related]
31. Blockade of PARP activity attenuates poly(ADP-ribosyl)ation but offers only partial neuroprotection against NMDA-induced cell death in the rat retina.
Goebel DJ; Winkler BS
J Neurochem; 2006 Sep; 98(6):1732-45. PubMed ID: 16903875
[TBL] [Abstract][Full Text] [Related]
32. Poly(ADP-ribose) polymerase activation mediates synchrotron radiation X-ray-induced damage of rodent testes by exacerbating DNA damage and apoptotic changes.
Sheng C; Chen H; Wang B; Wang C; Lin L; Li Y; Ying W
Int J Radiat Biol; 2014 Jul; 90(7):580-6. PubMed ID: 24669777
[TBL] [Abstract][Full Text] [Related]
33. The effect of poly (ADP-ribose) polymerase inhibition on aminoglycoside-induced acute tubular necrosis in rats.
Biro A; Vaknine H; Cohen-Armon M; Matas Z; Fux A; Schreiber L; Berger E; Dan M; Boaz M; Gregoriev O; Katzir Z
Clin Nephrol; 2016 Apr; 85(4):226-34. PubMed ID: 26951968
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis.
Wang J; Hao L; Wang Y; Qin W; Wang X; Zhao T; Liu Y; Sheng L; Du Y; Zhang M; Lu Q
Mol Med Rep; 2015 Mar; 11(3):1768-76. PubMed ID: 25412407
[TBL] [Abstract][Full Text] [Related]
35. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.
Turunc Bayrakdar E; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
Free Radic Res; 2014 Feb; 48(2):146-58. PubMed ID: 24151909
[TBL] [Abstract][Full Text] [Related]
36. 5-AIQ inhibits H2O2-induced apoptosis through reactive oxygen species scavenging and Akt/GSK-3β signaling pathway in H9c2 cardiomyocytes.
Park ES; Kang JC; Kang DH; Jang YC; Yi KY; Chung HJ; Park JS; Kim B; Feng ZP; Shin HS
Toxicol Appl Pharmacol; 2013 Apr; 268(1):90-8. PubMed ID: 23352507
[TBL] [Abstract][Full Text] [Related]
37. [Renal tubular dysfunction in patients with rheumatoid arthritis starting with low dose of methotrexate].
Wiland P; Wiela-Hojeńska A; Swierkot J; Hurkacz M; Orzechowska-Juzwenko K; Szechiński J
Pol Arch Med Wewn; 2003 Aug; 110(2):855-62. PubMed ID: 14682224
[TBL] [Abstract][Full Text] [Related]
38. Aminoguanidine, a selective nitric oxide synthase inhibitor, attenuates cyclophosphamide-induced renal damage by inhibiting protein nitration and poly(ADP-Ribose) polymerase activation.
Abraham P; Rabi S
Chemotherapy; 2011; 57(4):327-34. PubMed ID: 21893984
[TBL] [Abstract][Full Text] [Related]
39. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation.
Minchenko AG; Stevens MJ; White L; Abatan OI; Komjáti K; Pacher P; Szabó C; Obrosova IG
FASEB J; 2003 Aug; 17(11):1514-6. PubMed ID: 12824290
[TBL] [Abstract][Full Text] [Related]
40. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
